Vodis Pharmaceuticals Inc. (CSE: VP)
Vodis Pharmaceuticals Inc. (CSE:VP; OTC:VDQSF) is positioned to be among the first pharmaceutical corporations in Canada to produce and market medical marijuana under license from Health Canada in accordance with the existing Narcotic Control Regulations (“NCR”) and the new Marihuana for Medical Purposes Regulations (“MMPR”) that came into effect on April 1, 2014. Vodis filed its MMPR in August 2013 and in January 2014 received a ‘ready to build’ letter from Health Canada. IT IS CURRENTLY AWAITING FINAL INSPECTION FROM HEALTH CANADA.
|Symbol||Name||Last Price||Change||% Change|